Instructions to Authors  by unknown
The Taiwanese Journal of Obstetrics and Gynecology (TJOG) is the 
official peer-reviewed and SCIE-indexed journal of the 
Taiwan Association of Obstetrics and Gynecology, which 
aims to promote and improve women’s health. The Journal 
is also indexed in MEDLINE, SCOPUS, EMBASE, and SIIC 
Data Bases, and is published quarterly by Elsevier.
Authors are welcome to submit reviews, original articles, 
short communications, case reports, research letters and 
correspondence in the field of obstetrics and gynecology. 
The Editorial Board requires authors to be in compliance 
with the Uniform Requirements for Manuscripts Submitted to 
Biomedical Journals (URMs), which are compiled by the 
International Committee of Medical Journal Editors 
(ICMJE); current URMs are available at http://www. 
icmje.org.
1. Manuscript Submission
Please use only one of the two following submission meth-
ods below. Do NOT submit your manuscript using both 
methods.
1.1. Submission by E-mail
Manuscripts (meaning all submission items, including all 
text, tables, artwork, cover letter, conflicts of interest 
disclosures, and any other required documents/material 
as detailed in Section 1.4.) can be submitted by e-mail to 
the Editorial Office at obsgyntw@tpts6.seed.net.tw.
1.2. Submission by Post
Three copies of the original manuscript, one copy of each 
of the applicable supporting documents detailed in 
Section 1.4., two Checklists (available at the end of these 
author instructions), and a disk (containing the electronic 
copies of the manuscript and supporting documents) can 
be posted to the Editorial Office, addressed to:
Dr Chih-Ping Chen
Editor-in-Chief,
Taiwanese Journal of Obstetrics and Gynecology (TJOG)
Taiwan Association of Obstetrics and Gynecology
5/F, No. 70, Min-Chuan W. Road, Taipei 104,
Taiwan, R.O.C.
Tel: (+ 886) 2-2568-4819
Fax: (+ 886) 2-2100-1476
1.3. Important Information
  Articles should be in Microsoft Word document format 
and prepared in the simplest form possible. We will 
add in the correct font, font size, margins and so on 
according to the Journal’s style.
  You may use automatic page numbering, but do NOT 
use other kinds of automatic formatting such as foot-
notes, headers and footers.
  Put text, references, table headings and tables, and figure 
legends in one file.
  Figures must be submitted as separate picture files, at the 
correct resolution and named according to the figure 
number and format, e.g., “Fig1.tif”, “Fig2.jpg”. Please see 
Section 8.8. for more information.
1.4. Supporting Documents
The following documents must be included in your submission 
(refer also to the Checklist that follows these author instruc-
tions). Items (1), (2) and (3) are mandatory. Items (4), (5) 
and (6) are required only if they are applicable to your 
manuscript.
(1)  Cover Letter. This must include the following information:
 title of the manuscript 
  corresponding author details (name, e-mail, mailing 
address, telephone and fax numbers) 
  a statement that the material contained in the 
manuscript has not been previously published and 
is not being concurrently submitted elsewhere 
  persons who do not fulfill the requirements to be 
listed as authors but who nevertheless contributed 
to the manuscript (such as those who provided 
writing assistance, for example) should be disclosed 
 signature of the corresponding author
(2)  Authorship & Conflicts of Interest Statement. Each 
author’s contribution to the manuscript should be 
listed. Any and all potential and actual conflicts of inter-
est should also be listed (see Section 2 for more infor-
mation). Please use the TJOG Authorship & Conflicts of 
Interest Statement form that follows these author instruc-
tions and that is also provided on the Journal’s website 
at www.tjog-online.com. Your signature and those of 
ALL your coauthors must be included.
(3)  Copyright Transfer Agreement. In the event that your 
manuscript is accepted for publication in the TJOG, you 
are required to transfer all copyright ownership in and 
relating to the work to the Taiwan Association of 
Obstetrics and Gynecology. Please use the TJOG Copyright 
Transfer Agreement form that follows these author 
instructions and that is also provided on the Journal’s 
website at www.tjog-online.com. Your signature and 
those of ALL your coauthors must be included.
(4)  Ethics Statement. Articles covering the use of human or 
animal samples in research, or human or animal experi-
ments must be accompanied by a letter of approval 
from the relevant review committee or authorities. See 
Section 3 for more information.
(5)  Consolidated Standards of Reporting Trials (CONSORT) 
flow chart for randomized controlled trials submitted 
for publication. See Section 4 for more information.
(6)  Copyright Permission. If you have reproduced or 
adapted material from other copyrighted sources, the 
letter(s) of permission from the copyright holder(s) to 
reproduce or adapt the copyrighted sources must be 
supplied. Otherwise, such material must be removed 
from your manuscript.
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2. Disclosure of Conflicts of Interest
A conflict of interest occurs when an individual’s objectivity 
is potentially compromised by a desire for financial gain, 
prominence, professional advancement or a successful out-
come. TJOG Editors strive to ensure that what is published in 
the Journal is as balanced, objective and evidence-based as 
possible. Since it can be difficult to distinguish between an 
actual conflict of interest and a perceived conflict of interest, 
the Journal requires authors to disclose all and any potential 
conflicts of interest.
Conflicts of interest may be financial or non-financial. 
Financial conflicts include financial relationships such as 
honoraria; educational grants; participation in speakers’ 
bureaus; membership, employment, consultancies, stock 
ownership, or other equity interest; expert testimony or pat-
ent-licensing arrangements. Non-financial conflicts include 
personal or professional relationships, affiliations, academic 
competition, intellectual passion, knowledge or beliefs that 
might affect objectivity.
Please ensure that the name of each author listed in your 
manuscript appears in either Section I or Section II on page 2 
of the TJOG Authorship & Conflicts of Interest Statement form (an 
author’s name cannot appear in both Section I and Section 
II of the form).
3. Ethical Approval of Studies and Informed Consent
For human or animal experimental investigations described 
in original articles, appropriate institutional review board or 
ethics committee approval is required, and such approval 
should be stated in the methods section of the manuscript. 
For those investigators who do not have formal ethics review 
committees, the principles outlined in the Declaration of 
Helsinki should be followed (World Medical Association. 
Declaration of Helsinki: ethical principles for medical research involv-
ing human subjects. Available at: http://www.wma.net/en/ 
30publications/10policies/b3/17c.pdf).
For work involving animals, the guidelines for their care 
and use that were followed should be stated in the methods 
section of the manuscript. For those investigators who do 
not have formal institutional guidelines relating to animal 
experiments, the European Commission Directive 86/609/EEC 
for animal experiments (available at http://ec.europa.eu/ 
environment/chemicals/lab_animals/legislation_en.htm) 
should be followed and the same should be stated in the 
methods section of the manuscript.
4. Reporting Clinical Trials
All randomized controlled trials submitted for publication 
should include a completed Consolidated Standards of 
Reporting Trials (CONSORT) flow chart (please go to 
http://www.consort-statement.org for more informa-
tion). The TJOG has adopted the ICMJE proposal that 
requires, as a condition of consideration for publication 
of clinical trials, registration in a public trials registry. 
Purely observational studies (those in which the assign-
ment of the medical intervention is not at the discretion 
of the investigator) will not require registration. Further 
information can be found at http://www.icmje.org.
5. Previous Publication or Duplicate Submission
Submitted manuscripts are considered with the understand-
ing that they have not been published previously in print or 
electronic format (except in abstract or poster form) and are 
not under consideration in totality or in part by another 
publication or electronic medium.
6. Basic Criteria
Articles should be written in English, using American 
English spelling, and meet the following basic criteria: the 
material is original, the information is important, the 
writing is clear and concise, the study methods are appro-
priate, the data are valid, and the conclusions are reason-
able and supported by the data.
For manuscripts that are judged by TJOG Editors to be 
written in poor English but otherwise worthy of consider-
ation for publication, authors are required to pay for the 
English polishing of their manuscript. Otherwise, the 
Editorial Office reserves the right to reject the manuscript for 
publication.
7. Article Categories
The categories of articles that are published in the Journal 
are listed and described below. Please select the category 
that best describes your paper. If your paper does not fall 
into any of these categories, please contact the Editorial 
Office.
7.1. Review Articles
These should aim to provide the reader with a balanced 
overview of an important and topical issue in research or 
clinical practice. They should cover aspects of a topic in 
which scientific consensus exists as well as aspects that 
remain controversial and are the subject of ongoing scien-
tific research. All articles and data sources reviewed 
should include information about the specific type of 
study or analysis, population, intervention, exposure, and 
tests or outcomes. All articles or data sources should be 
selected systematically for inclusion in the review and crit-
ically evaluated.
7.2. Original Articles
These articles typically include randomized trials, inter-
vention studies, studies of screening and diagnostic tests, 
laboratory and animal studies, cohort studies, cost-effec-
tiveness analyses, case-control studies, and surveys with 
high response rates, which represent new and significant 
contributions to the field.
Section headings should be: Abstract, Introduction, 
Materials and methods, Results, Discussion, Acknowledgments 
(if any), and References.
The Introduction should provide a brief background to 
the subject of the paper, explain the importance of the 
study, and state a precise study question or purpose.
The Materials and methods section should describe 
the study design and methods (including the study setting 
and dates, patients/participants with inclusion and exclu-
sion criteria, patient samples or animal specimens used, 
the essential features of any interventions, the main out-
come measures, the laboratory methods followed, or data 
sources and how these were selected for the study), and 
state the statistical procedures employed in the research.
The Results section should comprise the study results 
presented in a logical sequence, supplemented by tables 
and/or figures. Take care that the text does not repeat data 
that are presented in tables and/or figures. Only emphasize 
and summarize the essential features of the main results.
The Discussion section should be used to emphasize the 
new and important aspects of the study, placing the results 
in context with published literature, the implications of the 
findings, and the conclusions that follow from the study 
results.
7.3. Short Communications
These should be concise presentations of preliminary experi-
mental results, instrumentation and analytical techniques, 
or aspects of clinical or experimental practice that are not 
fully investigated, verified or perfected but which may be of 
widespread interest or application.
Section headings should be: Abstract, Introduction, 
Materials and methods, Results, Discussion, Acknowledgments 
(if any), and References.
The Editors reserve the right to decide what constitutes a 
Short Communication.
7.4. Case Reports
These are short discussions of a case or case series with 
unique features not previously described that make an 
important teaching point or scientific observation. They 
may describe novel techniques or use of equipment, or new 
information on diseases of importance. Section headings 
should be: Abstract, Introduction, Case report, Discussion, 
Acknowledgments (if any), and References.
The Introduction should describe the purpose of the 
present report, the significance of the disease and its specifi-
city, and briefly review the relevant literature.
The Case report should include the general data of the 
case, medical history, family history, chief complaint, present 
illness, clinical manifestation, methods of diagnosis and 
treatment, and outcome.
The Discussion should compare, analyze and discuss the 
similarities and differences between the reported case and 
similar cases reported in other published articles. The impor-
tance or specificity of the case should be restated when dis-
cussing the differential diagnoses. Suggest the prognosis of 
the disease and possibility of prevention.
7.5. Research Letters
These include short interesting case reports that do not meet 
the requirement of being truly exceptional. Research Letters 
do not require an abstract and headings of Introduction, 
Case report and Discussion. The Editors reserve the right to 
decide what constitutes a Research Letter.
7.6. Correspondence
Brief constructive comments in response to previously pub-
lished TJOG articles or relating to a topical subject in the 
field, as well as other communications of general interest are 
welcome. They are edited, sometimes extensively, to sharpen 
their focus. They may be sent for peer review at the discretion 
of TJOG Editors.
Correspondence should have a title, and the correspond-
ing author’s mailing and e-mail addresses.
7.7. Editorials
Editorials are invited comments concerning a specific paper 
in the Journal or a topical issue in the field. While normally 
invited, unsolicited editorials may be submitted and will be 
given due consideration.
8. Manuscript Preparation
Text should be typed double-spaced on white A4 (297 X 
210 mm) paper, with outer margins of 2.5 cm. The manu-
script should include a title page, abstract and keywords, 
text, acknowledgments (if any), references, and figures 
and tables as appropriate. Each section of the manuscript 
should begin on a new page. Pages should be numbered 
consecutively, beginning with the title page.
8.1. Title Page
The title page should contain the following information (in 
order, from the top to bottom of the page):
  article category
 article title
  names (spelled out in full) of all authors*, and the institu-
tions with which they are affiliated; indicate all affiliations 
with a superscripted lowercase letter after the author’s 
name and in front of the matching affiliation
 conflicts of interest statement**
  corresponding author details (name, e-mail, mailing 
address, telephone and fax numbers)
*The name of each author should be written with the family name 
last, e.g., Wan-Lin Chang. Authorship is restricted only to direct par-
ticipants who have contributed significantly to the work.
**Since it is difficult to distinguish between an actual conflict of inter-
est and a perceived conflict of interest, the TJOG requires authors to 
disclose all and any potential conflicts of interest and let readers judge 
for themselves. Therefore, please ensure that you provide information 
about any potential financial and non-financial conflicts of interest 
(see Section 2 for more information) in a concise statement before the 
corresponding author details.
8.2. Abstracts and Keywords
An abstract of no more than 250 words and up to 6 relevant 
keywords (in alphabetical order) are required for the follow-
ing article categories: Review Articles, Original Articles, Short 
Communications, and Case Reports.
Abstracts for Review Articles should be unstructured 
(in one single paragraph with no section headings).
Abstracts for Original Articles and Short Communications 
should be structured into the following sections. Objective: 
briefly explain the importance of the study topic and state 
a precise study question or purpose. Materials and methods: 
briefly introduce the methods used to perform the study; 
include information on the study design, setting, subjects, 
interventions, outcome measures and analyses as appro-
priate. Results: briefly present the significant results, with 
data and statistical details such as p values where appro-
priate; be sure that information in the abstract matches 
that in the main text. Conclusion: state the meaning of your 
findings, being careful to address the study question 
directly and to confine your conclusions to aspects cov-
ered in the abstract; give equal emphasis to positive and 
negative findings.
Abstracts for Case Reports should be structured into 
the following sections. Objective: state the specific purpose 
of the work. Case report(s): summarize the pertinent fea-
tures of the clinical findings, important laboratory abnor-
malities, treatment, and outcomes. Conclusion: summarize 
the principal findings.
Keywords should be taken from the Medical Subject 
Headings (MeSH) list of Index Medicus (http://www.nlm.
nih.gov/mesh/meshhome.html).
No abstract or keywords are required for Research 
Letters, Correspondence and Editorials.
8.3. Main Text
The text for Original Articles and Short Communications 
should be organized into the following sections: 
Introduction, Materials (or Patients) and methods, Results, 
Discussion, and References. The Introduction should discuss 
the objective of the reported work and provide relevant back-
ground information. The Materials and methods should 
identify the population or patient samples in the study and 
explain the methods used. The Results should explain all the 
important findings and provide information about the accu-
racy and reliability of the results. The Discussion should state 
the implications of the findings and any conclusions based 
on the findings.
Sections for Case Reports are: Introduction, Case 
Report(s), Discussion, and References.
The text for Review Articles should be divided into logical 
sections with appropriate headings.
The text For Research Letters, Correspondence and 
Editorials should be in one single section with appropriate 
paragraphs, but there should be no section headings.
Please note that writing errors will result in immediate 
rejection of the paper.
8.3.1. Abbreviations
Where a term/definition will be continually referred to, it 
must be written in full when it first appears in the text, fol-
lowed by the subsequent abbreviation in parentheses. 
Thereafter, the abbreviation may be used. An abbreviation 
should not be first defined in any section heading; if an 
abbreviation has previously been defined in the text, then 
the abbreviation may be used in a subsequent section 
heading. Restrict the number of abbreviations to those 
that are absolutely necessary.
8.3.2. Numbers
Numbers that begin a sentence or those that are less than 10 
should be spelled out using letters. Centuries and decades 
should be spelled out, e.g., the Eighties or nineteenth century. 
Laboratory parameters, time, temperature, length, area, 
mass, and volume should be expressed using digits.
8.3.3. Units
Système International (SI) units must be used, with the 
exception of blood pressure values which are to be reported 
in mmHg. Use the metric system for the expression of length, 
area, mass, and volume. Temperatures are to be given in 
degrees Celsius.
8.3.4. Names of drugs, devices and other products
Use the Recommended International Non-proprietary Name 
(rINN) for medicinal substances, unless the specific trade 
name of a drug is directly relevant to the discussion. Generic 
drug names should appear in lowercase letters in the text. If 
a specific proprietary drug needs to be identified, the brand 
name may appear only once in the manuscript in parenthe-
ses following the generic name the first time the drug is men-
tioned in the text.
For devices and other products, the specific brand or 
trade name, the manufacturer and their location (city, state, 
country) should be provided the first time the device or 
product is mentioned in the text, for example, “…SPSS ver-
sion 11 was used (SPSS Inc., Chicago, IL, USA)”. Thereafter, 
the generic term (if appropriate) should be used.
8.3.5. Gene nomenclature
Current standard international nomenclature for genes 
should be adhered to. For human genes, use genetic notation 
and symbols approved by the HUGO Gene Nomenclature 
Committee (http://www.genenames.org). You may also refer 
to the resources available on PubMed at http://www.ncbi.
nlm.nih.gov/guide/genes-expression. The Human Genome 
Variation Society has a useful site that provides guidance in 
naming mutations at http://www.hgvs.org/mutnomen/
index.html. In your manuscript, genes should be typed in 
italic font and include the accession number.
8.3.6. Statistical requirements
Statistical analysis is essential for all research papers except 
Case Reports. Use correct nomenclature for statistical meth-
ods (e.g., two sample t test, not unpaired t test). Descriptive 
statistics should follow the scales used in data description. 
Inferential statistics are important for interpreting results 
and should be described in detail.
All p values should be presented to the third decimal 
place for accuracy. The smallest p value that should be 
expressed is p < 0.001 since additional zeros do not convey 
useful information; the largest p value that should be 
expressed is p > 0.99.
8.3.7. Personal communications and unpublished data
These sources cannot be included in the references list but 
may be described in the text. The author(s) must give the full 
name and highest academic degree of the person, the date of 
the communication, and indicate whether it was in oral or 
written (letter, fax, e-mail) form. A signed statement of 
permission should be included from each person identified 
as a source of information in a personal communication or 
as a source for unpublished data.
8.4. Funding/Support Statement
All financial and material support for the research, work, 
writing and editorial assistance from internal or external 
agencies, including commercial companies, should be clearly 
and completely identified in a Funding/Support Statement 
in a concise paragraph after the main text.
8.5. Acknowledgments
After the Funding/Support Statement (if any), general 
acknowledgments for consultations and statistical analy-
ses should be listed concisely, including the names of the 
individuals who were directly involved. Consent should be 
obtained from those individuals before their names are 
listed in this section. Those acknowledged should not 
include secretarial, clerical or technical staff whose par-
ticipation was limited to the performance of their normal 
duties.
8.6. References
Authors are responsible for the accuracy and completeness 
of their references and for correct in-text citation. 
8.6.1. In the main text, tables and figure legends
  References should be indicated by numbers in square 
brackets in line with the text, and numbered consecu-
tively according to order of appearance in the text. [The 
actual authors can be referred to, but the reference 
number(s) must always be given.]
  References cited in tables or figure legends should be 
included in sequence at the point where the table or fig-
ure is first mentioned in the main text.
  Do not cite abstracts unless they are the only available 
reference to an important concept.
  Do not cite uncompleted work or work that has not yet 
been accepted for publication (i.e., “unpublished obser-
vation”, “personal communication”) as references. Also 
see Section 8.3.7.
8.6.2. In the references list
  References should be compiled at the end of the man-
uscript according to the order of citation in the text, 
i.e., in numerical order, NOT alphabetical order.
  References should be limited to those cited in the text only.
  Journal references should include, in order, authors’ 
surnames and initials, article title, abbreviated journal 
name, year, volume and inclusive page numbers.
  The surnames and initials of all the authors up to 6 
should be included, but when authors number 7 or 
more, list the first 6 authors only followed by “et al”.
  Abbreviations for journal names should conform to 
those used in MEDLINE.
  If citing a website, provide the author information, arti-
cle title, website address and the date you accessed the 
information.
  Reference to an article that is in press must state the 
journal name and, if possible, the year and volume.
Examples of the most common reference types are 
provided below. (Please pay particular attention to the 
formatting, word capitalization, spacing and style.)
Standard journal article
Kanamori C, Kanamori T, Tanaka Y, Kanzaki H. Three-cycle 
fentanyl patch system contributes to stable control of 
plasma fentanyl concentration in gynecologic cancer pain 
patients. Taiwan J Obstet Gynecol 2011;50:79–84.
Journal article with more than 6 authors
Chen CP, Wu PC, Lin CJ, Chern SR, Tsai FJ, Lee CC, et al. 
Unbalanced reciprocal translocations at amniocentesis. 
Taiwanese J Obstet Gynecol 2011;50:48–57.
Journal supplement
Kaplan NM. The endothelium as prognostic factor and ther-
apeutic target: what criteria should we apply? J Cardiovasc 
Pharmacol 1998;32(Suppl 3):S78–80.
Journal article not in English but with English abstract
Hofele C, Schwager-Schmitt M, Volkmann M. Prognostic 
value of antibodies against p53 in patients with oral squamous 
cell carcinoma—five years survival rate. Laryngorhinootologie 
2002;81:342–5. [In German, English abstract]
Book with edition
Bradley EL. Medical and surgical management. 2nd ed. 
Philadelphia: Saunders; 1982.
Book with editors
Letheridge S, Cannon CR, editors. Bilingual educa-
tion: teaching English as a second language. New York: 
Praeger; 1980.
Book chapter in book with editor and edition
Greaves M, Culligan DJ. Blood and bone marrow. 
In: Underwood JCE, editor. General and systematic 
pathology. 4th ed. London: Churchill Livingstone; 2004, 
p. 615–72.
Book series with editors
Wilson JG, Fraser FC, editors. Handbook of teratology, vols. 
1–4. New York: Plenum Press; 1977–1978.
Bulletin
World Health Organization. World health report 2002: 
reducing risk, promoting healthy life. Geneva, Switzerland: 
World Health Organization; 2002.
Electronic publications
Duchin JS. Can preparedness for biological terrorism save us 
from pertussis? Arch Pediatr Adolesc Med 2004;158(2). 
Available at http://archpedi.ama-assn.org/cgi/content/
full/158/2/106. Accessed June 12, 2004.
Smeeth L, Iliffe S. Community screening for visual 
impairment in the elderly. Cochrane Database Syst Rev 
2002(2):CD001054. Doi:10.1002/14651858.CD1001054.
Item presented at a meeting but not yet published
Khuri FR, Lee JJ, Lippman SM. Isotretinoin effects on head 
and neck cancer recurrence and second primary tumors. In: 
Proceedings from the American Society of Clinical Oncology, 
May 31–June 3, 2003; Chicago, IL, abstract 359.
Item presented at a meeting and published
Cionni RJ. Color perception in patients with UV- or blue-
light-filtering IOLs. In: Symposium on cataract, IOL, and 
refractive surgery. San Diego, CA: American Society of 
Cataract and Refractive Surgery; 2004, abstract 337.
Thesis
Ayers AJ. Retention of resin restorations by means of enamel 
etching and by pins [MSD thesis]. Indianapolis: Indiana 
University; 1971.
Website
Glueckauf RL, Whitton J, Baxter J. Videocounseling for families 
of rural teens with epilepsy—project update. Telehealth News 
1998. Available at http://www.telehealth.net/subscribe/
newslettr_4a.html#1. Accessed November 15, 2008.
Company/manufacturer publication/pamphlet
Eastman Kodak Company, Eastman Organic Chemicals. 
Catalog no. 49. Rochester, NY: Eastman Kodak; 1977, 
p. 2–3.
8.7. Tables
Tables should supplement, not duplicate, the text. They 
should have a concise table heading, be self-explanatory, 
and numbered consecutively in the order of their citation 
in the text. Items requiring explanatory footnotes should 
be denoted using superscripted lowercase letters (a, b, c, 
etc.), with the footnotes arranged under the table in 
alphabetical order. Asterisks (*, **) are used only to indi-
cate the probability level of tests of significance. 
Abbreviations used in the table must be defined and 
placed after the footnotes in alphabetical order. If you 
include a block of data or table from another source, 
whether published or unpublished, you must acknowl-
edge the original source.
8.8. Figures
8.8.1. General guidelines
The number of figures should be restricted to the minimum 
necessary to support the textual material. Figures should 
have an informative figure legend and be numbered in the 
order of their citation in the text. All symbols and abbrevia-
tions should be defined in the figure legend in alphabetical 
order. Items requiring explanatory footnotes should follow 
the same style as that for tables as described in Section 8.7.
Patient identification should be obscured. All lettering 
should be done professionally and should be in proportion 
to the drawing, graph or photograph. Photomicrographs 
must include an internal scale marker, and the legend should 
state the type of specimen, original magnification and stain.
Figures must be submitted as separate picture files, at the 
correct resolution (see Section 8.8.2.) and named according 
to the figure number and format, e.g., “Fig1.tif”, “Fig2.jpg”.
8.8.2. Formats
Regardless of the application used, when your electronic art-
work is finalized, please “save as” or convert the images to 
one of the following formats (note the resolution require-
ments for line drawings, halftones, and line/halftone combi-
nations given below):
  EPS: vector drawings. Embed the font or save the text as 
“graphics”.
  TIFF: color or grayscale photographs (halftones)—use a 
minimum of 300 dpi.
  TIFF: bitmapped line drawings—use a minimum of 1000 
dpi.
  TIFF: combination of bitmapped line/halftone (color or 
grayscale)—use a minimum of 600 dpi.
  DOC, XLS or PPT: if your electronic artwork is created in 
any of these Microsoft Office applications, please supply 
“as is”.
Please do not:
  Supply files that do not meet the resolution requirements 
detailed above;
  Supply files that are optimized for screen use (such as 
GIF, BMP, PICT, WPG) as the resolution is too low;
  Submit graphics that are disproportionately large for the 
content.
A detailed guide on electronic artwork is available at http://www. 
elsevier.com/artworkinstructions.
9. The Editorial and Peer Review Process
Manuscripts are reviewed by the Editorial Office to ensure 
that the submission contains all parts. The submission will 
not be accepted if the author has not supplied all parts of 
the manuscript as outlined in this document.
Manuscripts are then forwarded to the Editor-in-Chief, 
who makes an initial assessment of it. If the manuscript does 
not appear to be of sufficient merit or is not appropriate for 
the Journal, then the manuscript will be rejected promptly 
without review.
Manuscripts that appear meritorious and appropriate 
for the Journal are reviewed by Editorial Board members 
or expert consultants assigned by the Editor-in-Chief. The 
selection of reviewers is at the sole discretion of TJOG 
Editors. The editors and reviewers will not disclose any 
information about a manuscript or its review to anyone 
except the manuscript’s corresponding author.
The corresponding author will be notified of whether the 
submitted article is accepted for publication, rejected, or 
subject to revision before acceptance. If revisions are 
required, authors are asked to return a revised manuscript to 
the Editorial Office via e-mail within 30 days. Please notify 
the Editorial Office in advance if additional time is needed or 
if you choose not to submit a revised manuscript.
For manuscripts that are judged by TJOG Editors to be 
written in poor English but otherwise worthy of considera-
tion for publication, authors are required to pay for the 
English polishing of their manuscript. Otherwise, their man-
uscript will be rejected.
10. Preparation for Publication
Once a manuscript has been accepted for publication, 
authors should submit the final version of their manuscript 
in MS Word format, with all tables/figures as applicable, via 
e-mail to the Editorial Office.
Accepted manuscripts are then presented to the 
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